Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Focan-Henrard

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Revue Medicale De Liege|December 1, 1972
[Value of the analysis of synovial fluid in rheumatology]D Focan-Henrard, P Franchimont
Revue Medicale De Liege|March 15, 1977
[Factors determining the prognosis of rheumatic pelvi-spondylitis]P Franchimont, D Focan-Henrard, G Heynen
Rheumatology|January 1, 1975
Radioimmunoassay of the rheumatoid factorsD Focan-Henrard, P Franchimont, E Bertrand
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Levamisole or placebo after effective chemotherapy for remission and survival prolongation in advanced human solid tumors--a double-blind randomized trialC Focan, J Schyns-Mosen, D Focan-Henrard
Pathologie-Biologie|July 11, 2003
[Randomised study to evaluate the chronotolerance of a combination infusional chemotherapy with 5-fluorouracil, folinic acid and carboplatin in non small cell lung cancer (NSCLC) patients]C Focan, F Kreutz, N Moeneclaye, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2000
Chronotherapy with 5-fluorouracil, folinic acid and carboplatin for metastatic colorectal cancer; an interesting therapeutic index in a phase II trialC Focan, F Kreutz, D Focan-Henrard, et al.
Pathologie-Biologie|July 11, 2003
[Chronobiological considerations for the management of human head and neck cancer]C Focan, D Focan-Henrard, F Kreutz, et al.
Pathologie-Biologie|July 11, 2003
[Evaluation of rest-activity rhythms in advanced non-small-cell lung cancer (NSCLC) patients. Importance of corticotherapy?]C Focan, C Mormont, N Moeneclaye, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Ambulatory chronotherapy with 5-fluorouracil, folinic acid, and carboplatin for advanced non-small cell lung cancer. A phase II feasibility trialC Focan, B Denis, F Kreutz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II trial with high-dose ifosfamide and mesna given in a 24-h infusion for advanced GI tract cancerC Focan, J Boossy, D Focan-Henrard, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Revue Medicale De Liege|December 1, 1972
[Value of the analysis of synovial fluid in rheumatology]D Focan-Henrard, P Franchimont
Revue Medicale De Liege|March 15, 1977
[Factors determining the prognosis of rheumatic pelvi-spondylitis]P Franchimont, D Focan-Henrard, G Heynen
Rheumatology|January 1, 1975
Radioimmunoassay of the rheumatoid factorsD Focan-Henrard, P Franchimont, E Bertrand
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Levamisole or placebo after effective chemotherapy for remission and survival prolongation in advanced human solid tumors--a double-blind randomized trialC Focan, J Schyns-Mosen, D Focan-Henrard
Pathologie-Biologie|July 11, 2003
[Randomised study to evaluate the chronotolerance of a combination infusional chemotherapy with 5-fluorouracil, folinic acid and carboplatin in non small cell lung cancer (NSCLC) patients]C Focan, F Kreutz, N Moeneclaye, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2000
Chronotherapy with 5-fluorouracil, folinic acid and carboplatin for metastatic colorectal cancer; an interesting therapeutic index in a phase II trialC Focan, F Kreutz, D Focan-Henrard, et al.
Pathologie-Biologie|July 11, 2003
[Chronobiological considerations for the management of human head and neck cancer]C Focan, D Focan-Henrard, F Kreutz, et al.
Pathologie-Biologie|July 11, 2003
[Evaluation of rest-activity rhythms in advanced non-small-cell lung cancer (NSCLC) patients. Importance of corticotherapy?]C Focan, C Mormont, N Moeneclaye, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Ambulatory chronotherapy with 5-fluorouracil, folinic acid, and carboplatin for advanced non-small cell lung cancer. A phase II feasibility trialC Focan, B Denis, F Kreutz, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II trial with high-dose ifosfamide and mesna given in a 24-h infusion for advanced GI tract cancerC Focan, J Boossy, D Focan-Henrard, et al.
Pageof 3